Institutional Ownership An2 Therapeutics, Inc. (ANTX)
This table provides information about the institutional ownership of An2 Therapeutics, Inc. (ANTX). We have compiled data on the 35 institutions that hold shares in the stock, with a total of 7.57 Million shares, which have been reported (via 13F filing form) to have a value of $8.63 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
14,281
shares
|
$16,280
0.0% of portfolio
|
Q3 2025
Reduced 16.56%
|
|
|
Act Advisors, Llc.
|
Oct 09, 2025 Q3 2025 |
13,199
shares
|
$15,046
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 03, 2025 Q3 2025 |
11,882
shares
|
$13,545
0.0% of portfolio
|
Q3 2025
Reduced 2.9%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
10,184
shares
|
$11,609
0.0% of portfolio
|
Q1 2025
Reduced 0.01%
|
|
|
ETF Managers Group, LLC
Summit, NJ |
Apr 17, 2023 Q1 2023 |
6,742
shares
|
$7,685
0.0% of portfolio
|
Q1 2023
New holding
|
|
|
Highline Wealth Partners LLC
Sherman Oaks, CA |
Oct 14, 2025 Q3 2025 |
5,000
shares
|
$5,699
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2025 Q3 2025 |
2,128
shares
|
$2,425
0.0% of portfolio
|
Q3 2025
Reduced 59.95%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 14, 2025 Q3 2025 |
300
shares
|
$341
0.0% of portfolio
|
Q4 2023
Added 50.0%
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Nov 04, 2025 Q3 2025 |
200
shares
|
$227
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|